Literature DB >> 17493546

Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort.

Manisha Chandalia1, Scott M Grundy, Beverley Adams-Huet, Nicola Abate.   

Abstract

Genetic susceptibility modulates the impact of obesity on the risk for type 2 diabetes. One candidate gene predisposing to type 2 diabetes is ENPP1/PC1. A common polymorphism in this protein, K121Q, is associated with insulin resistance and increased susceptibility to type 2 diabetes in Caucasian, Afro-Caribbean, and South Asian populations. The goal of this study was to evaluate differences in the prevalence of the ENPP1 121Q variant in the Caucasian, African-American, and Hispanic populations in Dallas county and to establish a population-based estimate of gene variant prevalence for future investigations. We also evaluated the association between the ENPP1 121Q variant and diabetes. The Dallas Heart Study (DHS) is a multiethnic probability-based sample of the Dallas county population in which African-Americans were systematically oversampled so that the final sample was 50% African-Americans. We performed ENPP1/PC1 genotyping in 1038 non-Hispanic Whites (544 women, 494 men), 1815 African-Americans (1052 women and 763 men), and 597 Hispanics (347 women, 250 men). The frequency of ENPP1/PC1 K121Q was higher in both African-Americans (78.5%) and Hispanics (21.9%) than in the non-Hispanic White group (13.2%). The former two groups also have a higher prevalence of type 2 diabetes (African-Americans, 14.1%, and Hispanics, 11.7%) compared to non-Hispanic Whites (6.8%). Logistic regression analysis revealed significant interactions between the ENPP1 genotype, age, and body mass index within each ethnic group. After adjustment for these variables and their interactions, ENPP1 Q allele predicted diabetes when a recessive model was tested. Ethnic differences in ENPP1 121Q allele frequency may contribute to the increased susceptibility to type 2 diabetes observed in US minority groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493546     DOI: 10.1016/j.jdiacomp.2006.11.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  20 in total

1.  Race and medication adherence and glycemic control: findings from an operational health information exchange.

Authors:  Vivienne J Zhu; Wanzhu Tu; David G Marrero; Marc B Rosenman; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

Review 2.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

Review 3.  Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Authors:  Piers R Blackett; Dharambir K Sanghera
Journal:  J Clin Lipidol       Date:  2012-04-22       Impact factor: 4.766

4.  A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.

Authors:  Lakshmi Subramanian; Abrar A Khan; Prasanna K R Allu; Malapaka Kiranmayi; Bhavani S Sahu; Saurabh Sharma; Madhu Khullar; Ajit S Mullasari; Nitish R Mahapatra
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

5.  New Insights into the Role of ENPP1 in Insulin Resistance.

Authors:  Wentong Pan; Manisha Chandalia; Nicola Abate
Journal:  J Metabonomics Metab       Date:  2012-10-15

6.  Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects.

Authors:  Sinan Tanyolaç; Andrew A Bremer; Uğur Hodoglugil; Irina Movsesyan; Clive R Pullinger; Steven W Heiner; Mary J Malloy; John P Kane; Ira D Goldfine
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

7.  Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.

Authors:  M R Irvin; H W Wiener; R P Perry; R M Savage; R C P Go
Journal:  Schizophr Res       Date:  2009-07-29       Impact factor: 4.939

8.  The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

Authors:  Allan F Moore; Kathleen A Jablonski; Clinton C Mason; Jarred B McAteer; Richard F Arakaki; Barry J Goldstein; Steven E Kahn; Abbas E Kitabchi; Robert L Hanson; William C Knowler; Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2008-11-18       Impact factor: 5.958

9.  Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.

Authors:  Intissar Ezzidi; Nabil Mtiraoui; Stéphane Cauchi; Emmanuel Vaillant; Aurélie Dechaume; Molka Chaieb; Maha Kacem; Wassim Y Almawi; Philippe Froguel; Touhami Mahjoub; Martine Vaxillaire
Journal:  BMC Med Genet       Date:  2009-04-15       Impact factor: 2.103

10.  Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites.

Authors:  Josiemer Mattei; Laurence D Parnell; Chao-Qiang Lai; Bibiana Garcia-Bailo; Xian Adiconis; Jian Shen; Donna Arnett; Serkalem Demissie; Katherine L Tucker; Jose M Ordovas
Journal:  BMC Genet       Date:  2009-08-14       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.